Cox proportional hazards model: time to acute GVHD in low DC group
Variable . | HR . | 95% CI . | P . |
---|---|---|---|
Low DC group | 3.32 | 1.48-7.45 | .04 |
CD34 infused, × 106/kg | 0.95 | 0.78-1.16 | .62 |
Log, ANC | 1.65 | 1.08-2.53 | .02 |
Patient age | 0.97 | 0.92-1.03 | .32 |
Patient sex male | 1.27 | 0.56-2.88 | .56 |
Donor age | 1.02 | 0.97-1.06 | .49 |
Donor sex male | 0.71 | 0.32-1.56 | .39 |
High disease risk | 0.87 | 0.20-3.82 | .85 |
Nonmyeloablative conditioning | 0.85 | 0.30-2.45 | .76 |
Variable . | HR . | 95% CI . | P . |
---|---|---|---|
Low DC group | 3.32 | 1.48-7.45 | .04 |
CD34 infused, × 106/kg | 0.95 | 0.78-1.16 | .62 |
Log, ANC | 1.65 | 1.08-2.53 | .02 |
Patient age | 0.97 | 0.92-1.03 | .32 |
Patient sex male | 1.27 | 0.56-2.88 | .56 |
Donor age | 1.02 | 0.97-1.06 | .49 |
Donor sex male | 0.71 | 0.32-1.56 | .39 |
High disease risk | 0.87 | 0.20-3.82 | .85 |
Nonmyeloablative conditioning | 0.85 | 0.30-2.45 | .76 |
P values determined by χ2 analysis.